Pfizer Enters AI Partnership with Boltz Following UBS Neutral Rating
Pfizer announced a strategic AI collaboration with Boltz to accelerate drug discovery, after UBS initiated coverage with a Neutral rating citing revenue uncertainty.
Topic
Latest reporting and analysis tagged with UBS rating.
Pfizer announced a strategic AI collaboration with Boltz to accelerate drug discovery, after UBS initiated coverage with a Neutral rating citing revenue uncertainty.